Akt phosphorylates both Tsc1 and Tsc2 in drosophila, but neither phosphorylation is required for normal animal growth

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Schleich, Sibylle ^a   Teleman, Aurelio A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HAMARTIN; INSULIN; PROTEIN KINASE B; PROTEIN TSC1; SERINE; TARGET OF RAPAMYCIN KINASE; TRIACYLGLYCEROL; TUBERIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DROSOPHILA PROTEIN; GIG PROTEIN, DROSOPHILA; PRIMER DNA; TSC1 PROTEIN, DROSOPHILA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DROSOPHILA; GENOTYPE; INSECT DEVELOPMENT; INSECT GENETICS; METABOLIC DISORDER; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE GROWTH; ANIMAL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION;

ANIMALIA; MAMMALIA;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; DNA PRIMERS; DROSOPHILA; DROSOPHILA PROTEINS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 67650917394     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006305     Document Type: Article

References (25)

1. Huang J, Manning BD (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412: 179-190.
2. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
3. Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12: 487-502.
4. Mayer C, Grummt I (2006) Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25: 6384-6391.
5. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10: 151-162.
6. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657.
7. Potter CJ, Pedraza LG, Xu T (2002) Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4: 658-665.
8. Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, et al. (2006) Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173: 279-289.
9. Dong J, Pan D (2004) Tsc2 is not a critical target of Akt during normal Drosophila development. Genes Dev 18: 2479-2484.
10. Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, et al. (2007) IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130: 440-455.
11. Bodenmiller B, Malmstrom J, Gerrits B, Campbell D, Lam H, et al. (2007) PhosphoPep-a phosphoproteome resource for systems biology research in Drosophila Kc167 cells. Mol Syst Biol 3: 139.
12. Teleman AA, Chen YW, Cohen SM (2005) Drosophila Melted modulates FOXO and TOR activity. Dev Cell 9: 271-281.
13. Hietakangas V, Cohen SM (2007) Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth. Genes Dev 21: 632-637.
14. Gao X, Pan D (2001) TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 15: 1383-1392.
15. Ito N, Rubin GM (1999) gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96: 529-539.
16. Staveley BE, Ruel L, Jin J, Stambolic V, Mastronardi FG, et al. (1998) Genetic analysis of protein kinase B (AKT) in Drosophila. Curr Biol 8: 599-602.
17. Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P, et al. (2003) Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol 5: 559-565.
18. Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, et al. (2003) Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol 5: 566-571.
19. Teleman AA, Chen YW, Cohen SM (2005) 4E-BP functions as a metabolic brake used under stress conditions but not during normal growth. Genes Dev 19: 1844-1848.
20. Hutti JE, Jarrell ET, Chang JD, Abbott DW, Storz P, et al. (2004) A rapid method for determining protein kinase phosphorylation specificity. Nat Methods 1: 27-29.
21. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9: 316-323.
22. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, et al. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25: 903-915.
23. Wang L, Harris TE, Roth RA, Lawrence JC Jr (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282: 20036-20044.
24. Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, et al. (2007) The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem 282: 20329-20339.
25. Fonseca BD, Smith EM, Lee VH, MacKintosh C, Proud CG (2007) PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 282: 24514-24524.